ABSTRACT Human polyomavirus (HPyV) DNA genomes contain three regions denoted the early viral gene region (EVGR), encoding the regulatory T-antigens and one microRNA, the late viral gene region (LVGR), encoding the structural Vp capsid proteins, and the noncoding control region (NCCR). The NCCR harbors the origin of viral genome replication and bidirectional promoter/enhancer functions governing EVGR and LVGR expression on opposite DNA strands. Despite principal similarities, HPyV NCCRs differ in length, sequence, and architecture. To functionally compare HPyV NCCRs, sequences from human isolates were inserted into a bidirectional reporter vector using dsRed2 for EVGR expression and green fluorescent protein (GFP) for LVGR expression. Transfecting HPyV NCCR reporter vectors into human embryonic kidney 293 (HEK293) cells and flow cytometry normalized to archetype BKPyV NCCR revealed a hierarchy of EVGR expression levels with MCPyV, HPyV12, and STLPyV NCCRs conferring stronger levels and HPyV6, HPyV9, and HPyV10 NCCRs weaker levels, while LVGR expression was less variable and showed comparable activity levels. Transfection of HEK293T cells expressing simian virus 40 (SV40) large T antigen (LTag) increased EVGR expression for most HPyV NCCRs, which correlated with the number of LTag-binding sites (Spearman's r, 0.625; P Ͻ 0.05) and decreased following SV40 LTag small interfering RNA (siRNA) knockdown. LTagdependent activation was specifically confirmed for two different MCPyV NCCRs in 293MCT cells expressing the cognate MCPyV LTag. HPyV NCCR expression in different cell lines derived from skin (A375), cervix (HeLaNT), lung (A549), brain (Hs683), and colon (SW480) demonstrated that host cell properties significantly modulate the baseline HPyV NCCR activity, which partly synergized with SV40 LTag expression. Clinically occurring NCCR sequence rearrangements of HPyV7 PITT-1 and -2 and HPyV9 UF1 were found to increase EVGR expression compared to the respective HPyV archetype, but this was partly host cell type specific.
lated by LTag expression and by host cell properties. Clinical sequence variants of HPyV7 and HPyV9 NCCRs containing deletions and insertions were associated with increased EVGR expression, similar to BKPyV and JCPyV rearrangements, emphasizing that HPyV NCCR sequences are major determinants not only of host cell tropism but also of pathogenicity. These results will help to define secondary HPyV cell tropism beyond HPyV surface receptors, to identify key viral and host factors shaping the viral life cycle, and to develop preclinical models of HPyV persistence and replication and suitable antiviral targets.
rearranged variants have not been reported so far. In fact, cell culture propagation of the novel HPyVs has been difficult, which severely limits studies of viral replication and antiviral targets. However, HPyV-host cell interactions have been studied at the level of viral capsid-receptor interactions defining primary HPyV cell tropism and entry (32, (38) (39) (40) . Yet, the NCCR defines a second level of host cell tropism after delivery of the viral genome into the nucleus, which is critical for coordinating and directing decisions regarding latency/persistence as well as progression through the viral life cycle (33) . To experimentally overcome the NCCR bottleneck, researchers have resorted to viral recombinants carrying genomes with hybrid NCCRs, e.g., between SV40 and JCPyV (41, 42) , or have provided SV40 EVGR proteins like the LTag in trans (43) (44) (45) (46) . To study the role of specific TFBS in archetype and rearranged HPyV NCCRs, we have chosen the archetype BKPyV NCCR as a model and introduced inactivating point mutations in 28 common TFBS (47) . We identified three phenotypic groups of (i) strong, (ii) intermediate, or (iii) low EVGR expression and the corresponding viral replication capacities (47) . Interestingly, a prominent role emerged for the TFBS of rather common host cell factors such as Sp1, Ets1, and NF1 (47) . Indeed, Sp1 was recently identified as essential for progressing into EVGR expression by whole-genome RNA interference screen (see Table  S2 in reference 48). However, point mutation analysis identified two key Sp1 sites, one each in the EVGR and the LVGR promoters, where they exerted different functions based on their location, directionality, and affinity and conferred graded activation of EVGR expression at the expense of LVGR expression (49) . When examining archetype NCCRs of the HPyVs, we found differences not only in NCCR length but also in the number and the composition of common TFBS and LTag binding sites. We therefore hypothesized that these NCCR differences give rise to different bidirectional EVGR and LVGR expression patterns. To this end, our results indicate the presence of a hierarchy of HPyV EVGR expression, which is modulated by host cell, LTag expression, and clinically occurring NCCR rearrangements.
(Parts of the results from this study have been presented as poster P19-1 on the occasion of the 6th Congress of the European Society of Virology, in Hamburg, Germany, 21 October 2016.)
RESULTS
HPyV NCCRs confer different strengths of EVGR expression. Given the prominent role of Sp1, Ets1, NF1, and LTag in the archetype BKPyV NCCR (33, 47, 49) , we compared the archetype NCCRs of BKPyV, JCPyV, and 11 novel HPyVs and found differences not only in the overall length but also in the number and composition of these binding sites (50) (Fig. 1 ; Table 1) .
LTag-binding sites were predicted in all HPyV NCCRs and preferentially located in the EVGR promoter region, numbering an average of 5, ranging from 1 and 2 for HPyV6 and HPyV7 to 10 and 12 for TSPyV and MCPyV NCCRs. NF1 sites were preferentially predicted in the LVGR, but some HPyV NCCRs had an average of one or less than one (MCPyV, HPyV6, HPyV7, HPyV9). Sp1, Ets1, and Spi-B sites were found in all HPyV NCCRs and often in clusters (Fig. 1) .
We therefore hypothesized that these differences in NCCR confer different bidirectional EVGR and LVGR expressions. To test this hypothesis, we compared 13 archetype HPyV NCCRs using a novel bifluorescent reporter vector, pRG13D12, recapitulating the PyV genome organization regarding bidirectional EVGR and LVGR ( Fig. 2A) . To validate its suitability (Fig. 2B) , NCCRs of the well-characterized archetype BKPyV(ww) and the rearranged BKPyV strain Dunlop (DUN) were inserted, and the resulting reporter constructs were transfected into HEK293 cells and analyzed by flow cytometry at 48 h posttransfection (hpt). Indeed, the rearranged BKPyV NCCR(DUN) conferred significantly stronger EVGR expression (shown in red) than did the archetype BKPyV(ww) NCCR, which was inversed in the reverse orientation (Fig. 2C ), in line with previous results (34, 47) . Quantification of the fluorescent cells (Fig. 2D ) and the mean fluorescence intensity (MFI) indicated that the simplified reporter vector pRG13D12 captured these differences (Fig. 2E) , hence being suitable for a principal comparative analysis of HPyV NCCRs.
To that end, 13 archetype HPyV NCCR sequences were inserted into pRG13D12, verified by sequencing, and transfected into human embryonic kidney (HEK293) cells. EVGR and LVGR expressions were quantified by flow cytometry, and the results were normalized to the archetype BKPyV NCCR(ww). The results demonstrated that EVGR expression in HEK293 cells varied over more than 3 orders of magnitude (Fig. 3A) . MCPyV and HPyV12 NCCRs were located at the upper end of the EVGR responses, whereas HPyV6 and HPyV9 NCCRs were found at the lower end. The corresponding LVGR expression also showed some variability but tended to be within the same order of magnitude (Fig. 3A) . The results indicated that HPyV NCCRs gave rise to a hierarchy of EVGR expression levels in HEK293, which were higher than, similar to, and lower than the corresponding archetype BKPyV NCCR activity in HEK293.
LTag activates HPyV NCCR-controlled EVGR expression. Since LTag is a major regulatory protein encoded by the EVGR and exerts key functions in viral replication and gene expression, parts of which are mediated directly through LTag-binding sites (Fig. 1, red triangles) , it was of interest to investigate the effect of LTag on HPyV NCCR reporter expression. To ensure comparable conditions for all 13 HPyV NCCRs, the well-characterized HEK293 derivative 293T cells were chosen, which constitutively express SV40 LTag (49) . Transfection and flow cytometry analysis 48 hpt showed that the overall hierarchy of EVGR expression was only little changed, whereby MCPyV and HPyV12 were in the higher group and HPyV6 and HPyV7 remained in the lower group (Fig. 3B) . However, JCPyV EVGR expression appeared to be most responsive to SV40
FIG 1
In silico prediction of common transcription factor-and LTag-binding sites in the NCCRs of 13 HPyVs. The BKPyVww NCCR was used as the reference as described in Materials and Methods (49) . HPyV NCCR length is shown in the brackets in base pairs. The direction of EVGR and LVGR transcription and the start codon (ATG) are depicted in red and green arrows, respectively. TSS, transcription start sites (marked by dashed arrows); inr, initiation element (in gray rectangle); DPE, downstream promoter element (in blue rectangle). Binding sites are indicated as follows: red triangles, LTag; yellow triangles, Sp1; green triangles, NF-B; black square, TATA box; gray square, TATA-like element; blue triangles, NF1; orange triangles, Ets1; light orange triangles, Spi-B; pink rectangles, origins of replication (ori). LTag and was now located among those HPyVs conferring NCCR-driven EVGR expression equal to or higher than that of BKPyV. Compared to HEK293, EVGR expression in HEK293T cells increased more than 10-fold for some HPyV NCCRs, including BKPyV, whereas only little change was observed for HPyV6. LVGR expression also increased but to a lesser extent (Fig. 3C) . Thus, most, but not all HPyV NCCRs were able to respond to SV40 LTag in trans with significantly increased EVGR expression.
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(1 and 2 sites, respectively) of LTag-binding sites, while MCPyV NCCR harbors the highest number (12 sites) of LTag-binding sites, which appeared to partly correlate with the EVGR expression levels in HEK293T cells (Spearman's correlation, r ϭ 0.625; P Ͻ 0.05) (Fig. 3D ). Of note, HPyV12 and TSPyV deviated by showing significantly higher and lower levels, respectively, than the others. To ensure a significant role of SV40 Tag expression in the observed increase in NCCR gene expression, 293T cells were first transfected with small interfering RNA (siRNA) targeting a common sequence of the sTag and LTag transcripts, and the results of sTag and LTag protein levels and corresponding bidirectional reporter gene expression were compared to those obtained with control cells transfected with scrambled siRNA (Fig. 4) . As shown for the NCCRs of BKPyV, JCPyV, KIPyV, MCPyV, and HPyV12, reporter gene expression at 72 hpt was reversed by the s/LTag siRNA. Together, the data indicated that SV40 LTag in trans provided an important stimulus to the basal EVGR expression of most HPyV EVGRs but also suggested that other factors related to the primary HPyV NCCR sequence mattered. Autologous MCPyV LTag increases MCPyV NCCR EVGR expression. Although SV40 LTag has considerable homology to the LTag encoded by HPyV genomes (32, 33), differences in amino acids and in the host range domain have been noted, which can be grouped in one of seven clades (51). We wondered whether or not the known strong and pleiotropic action of SV40 LTag in 293T cells could be an appropriate indicator and surrogate of the cognate viral LTag. We addressed this question for MCPyV by examining two MCPyV NCCR reporter constructs in 293MCT cells (52) expressing the cognate MCPyV LTag (Fig. 5A) . One NCCR had been detected in healthy skin and was tested previously (MCPyV-R17b) (9) , while the other one had been detected in a Merkel cell carcinoma carrying 1 C¡G substitution and 1 A base deletion in an A-rich sequence stretch (MCPyV-MCVw156) (53) . The results demonstrated increased EVGR expression from two different MCPyV NCCRs in 293MCT cells, thus independently supporting the results obtained with SV40 LTag in 293T cells (Fig. 5B, C, and D) . Rearranged NCCR patient variants increase EVGR expression. Clinical NCCR sequence variants of the novel HPyVs have been described (24, 31, 54) , but their effects on bidirectional EVGR and LVGR expression have not been compared with the respective archetype NCCRs. We therefore examined the rearranged HPyV7 NCCR variants PITT1 and PITT2 (Fig. 6A ) detected in two lung transplant patients with pruritic hyperproliferative keratinopathy (24) . The data demonstrated a significant increase of HPyV7 PITT1 and PITT2 EVGR expression in the colon cell line SW480, while only a trend to higher levels was observed in HEK293 (Fig. 6A) . For the rearranged HPyV9-UF1 (Fig.  6B ), higher EVGR expression over archetype HPyV9 NCCR activity was observed in HEK293 and in the lung cancer line A549 (Fig. 6B) . These results indicated that naturally occurring NCCR rearrangements of the novel HPyV7 and -9 were able to confer increased EVGR expression but that this effect also depended on the host cell context.
Role of host cells for bidirectional NCCR expression. Given the role of the host cell context suggested above, we analyzed the NCCR-driven EVGR and LVGR expressions of the 13 HPyV NCCR reporter constructs in different cell lines derived from skin, lung, cervix, brain, and colon (Tables 2 and 3) . Indeed, HPyV NCCR showed differences in EVGR and LVGR expression according to the host cell lines tested (Table 2) . Thus, MCPyV demonstrated the strongest EVGR expression in the skin-derived A375 cells and intermediate levels in the epithelial cell lines derived from kidney and colon, whereas cervix, lung, and brain cell lines showed rather low EVGR expression. HPyV12 NCCR conferred the strongest expression in brain and colon, followed by lung, cervix, and skin cell lines, while remaining relatively low in kidney-derived cell lines. JCPyV NCCR EVGR expression was highest in brain-derived cells, whereas BKPyV NCCR showed the highest EVGR expression in kidney, followed by lung-and colon-derived cell lines. KIPyV NCCR-driven EVGR expression was highest in cervix and brain followed by lung, while WUPyV NCCR was highest in the colon-derived cell line ( Table 2) . Complementary LVGR expression levels were observed for these HPyV NCCRs, some of which decreased as the EVGR expression levels were higher. Taken together, the data demonstrate that the bidirectional activity of a given HPyV can substantially differ in different host cells.
To investigate whether or not expression of SV40 LTag in trans would be able to further increase the host cell-specific expression levels, A375 skin and SW480 colonderived cells were transfected with a corresponding LTag expression vector, pRcCMV-SLT or pSG-largeT (data not shown). The results indicated that MCPyV NCCR-driven EVGR expression was significantly increased in both cell lines expressing SV40 LTag, whereas no significant changes were observed for HPyV12 NCCR-driven reporter gene expression (Fig. 7) .
DISCUSSION
The results of the present study demonstrate that HPyV NCCRs not only differ in sequence length, number, and position of binding sites for LTag and rather common factors like Sp1, NF1, and Ets1 (Fig. 1) but also confer significant differences in viral gene expression. This difference in basal EVGR expression is most impressively captured in HEK293 cells by the high levels seen for MCPyV and HPyV12 NCCRs at the upper end, and which range to the 2-orders-of-magnitude-lower levels seen for HPyV6, HPyV7, and HPyV9 NCCRs. LVGR expression was generally strong but varied less among the different archetype HPyV NCCRs as described for the archetype BKPyV NCCR(ww) (34, 36) .
The functionality of the bidirectional HPyV NCCR reporter activity was further addressed by providing the SV40 homolog of the EVGR-encoded LTag in trans (32, 55) in 293T cells, which showed increased EVGR expression levels for practically all HPyV NCCRs. This indicates that the reporter construct recapitulated an essential NCCR response described in detail for the viral life cycle of polyomavirus representatives such as SV40 or BKPyV (1, 32, 34, 47) . LVGR expression was also increased, although to a lesser extent, in line with the bidirectional balance of EVGR versus LVGR expression (49) . Knockdown of SV40 Tag following siRNA transfection of 293T resulted in decreased LTag expression and lowered reporter gene expression, indicating that LTag played a significant role rather than undefined clonal cell variation. Although SV40 LTag has been recognized and exploited as a strong pleiotropic activator of HPyV gene expression, the autologous LTag of some HPyVs might confer only selective responses, as reported for the JCPyV LTag and its cognate JCPyV NCCR, which are not seen for BKPyV NCCR (56). We could not assess the specific impact of each of the 13 HPyV LTag orthologues on their respective NCCRs, but our observations were supported by the impact of MCPyV LTag on 293MCT cells (52) demonstrating a similar activation of EVGR expression for two different MCPyV NCCRs, one from a healthy control and one from a Merkel cell carcinoma bearing a G-to-C point mutation.
The role of the HPyV NCCR sequences as differential determinants of EVGR and LVGR expression was further strengthened by the correlation of the number of LTag-binding sites and the level of EVGR expression in 293T cells. However, there were also two notable exceptions, such as HPyV12 NCCR, which showed much higher EVGR expression than predicted from the number of LTag-binding sites, whereas the opposite was true for the TSPyV NCCR EVGR response. This suggested that other regulatory elements were critical in determining the EVGR response. In this analysis, the higher expression of rearranged BKPyV(DUN) NCCR compared to the archetype BKPyVww should be noted, in which one LTag site is deleted together with the high-affinity SP1-4 site in the LVGR promoter (49) . Deletions and insertions in HPyV7 PITT1, HPyV PITT2, and HPyV9 UF1 were also associated with increased EVGR expression despite rather small alterations of the primary sequence. Thus, HPyV NCCR sequences are key determinants of EVGR activity, and this suggests for the first time that the pathogenicity of the rearranged variants would likely be increased in susceptible host cells as shown before for clinical variants of BKPyV and JCPyV NCCRs (34, 37) . Finally, we noted that HPyV NCCR expression levels differed in different host cell lines, emphasizing that the combined cellular make-up of transcription factors and other regulatory proteins is essential in sensing and interpreting the HPyV NCCRs with respect to viral gene expression and persistence (33) . Transfection of skin-and colonderived cells with an SV40 LTag expression vectors provided evidence that MCPyV NCCR-driven EVGR expression could be further increased, most prominently in the SW480 colon-derived cells, whereas this was not the case for the HPyV12 NCCR in these cells, indicating that the NCCR and specific host cell factors may be critical also for LTag-mediated effects.
As this work was in progress, Moens and colleagues independently reported the characterization of HPyV NCCRs in different cell lines using a unidirectional luciferase reporter assay, which identified higher EVGR expression by MCPyV and HPyV12 NCCRs, similar to our results, but also for TSPyV NCCR (57), which was not seen in our study. Although unidirectional reporter assays have been commonly used, they remain challenging for a bidirectional gene expression organization within a small DNA sequence of approximately 500 bp (Fig. 1) . Part of this stems from the difficulty to generate well-justified and controlled truncations of the intricately intertwined and competing functional elements of the bidirectional HPyV NCCR (47, 49) , which may be difficult to accomplish given the pronounced functional effects of even single-point mutations (47) . Unfortunately, their approach is also faced with the difficulty of ensuring directly equivalent transfection efficacies for each of their unidirectional assessments of the early gene expression and then again of the late gene expression (57) . These caveats render a straightforward assessment of the early versus late activity difficult. Most notably, the unidirectional approach may be subject to undefined and possibly host cell-dependent effects from the direct joining of unrelated plasmid sequences, which arise from NCCR truncation on the opposite end of the reporter gene. Experimental studies of the SV40 NCCR have shown that unrelated sequences can have substantial effects on NCCR function (58, 59 ). This may be responsible for some of the discrepancies between the unidirectional approach and the more-physiological bidirectional approach used by us. Among others, Moens et al. reported the highest MCPyV-EVGR expression in the colon cell line (SW480), whereas we observed the highest expression level in skin-derived A375 cells (57) . Moreover, we demonstrate that the lower levels of MCPyV-EVGR expression in the colon cell line (SW480) could be further increased by LTag expression. Together with our previous analyses (34, 37), we are confident that the bidirectional reporter assays used here recapitulates the physiological HPyV NCCR organization and activity, which can be robustly enumerated in single cells using flow cytometry and includes estimates of nontransfected nonfluorescent cells (47, 49) .
Our comprehensive analysis of the bidirectional HPyV NCCR reporter expression using flow cytometry also provides estimates for different model cell lines derived from kidney, skin, lung, cervix, colon, and brain. The results suggest that there may be underlying mechanisms linked to cell differentiation and the respective HPyV NCCR as expected for a coevolutionary relationship. Thus, EVGR expression of MCPyV NCCR was even stronger in skin-derived cell line A375 than in the kidney-derived reference HEK293 or 293T derivative cell line, whereas that of BKPyV NCCR was strongest in kidney-derived, and that of WUPyV in colon-derived, cell lines (Table 1) . Although identifying these promoting or restricting factors in the respective cell lines requires further study, their nonrandom viral expression profile is intriguing and suggests a first functional characterization of secondary HPyV host cell tropism through this bidirectional reporter assay. The combination of host cell and HPyV NCCR reporter vector should be amenable to molecular screening approaches using loss-of-function approaches, e.g., through short hairpin RNA (shRNA) knockdown libraries as reported previously (48) , or gain-of-function approaches, e.g., through expression library or corresponding small-compound libraries. Clearly, our correlation of functional response and NCCR sequence does not presently allow to simply delineate candidate sequences or factors but requires further fine mapping as done for the BKPyV NCCR (47) . In this regard, the current lack of straightforward HPyV culture and replication models must be acknowledged as a limitation. This obstacle is somewhat at odds with the rather frequent detection of certain HPyVs such as HPyV6 and HPyV7 on healthy skin and the rather poor NCCR expression levels observed here as well as by others, which suggests that important host cell factors must be identified before cell culture work can be successful.
The high number of HPyVs in humans continues to surprise (60) , as comprehensive serological studies using specific Vp1-based IgG detection indicate that most humans have been infected with more than one (17) (18) (19) 61) . On average, 6 to 7 HPyV coinfections are present (19) , some which may coexist in the same organ as shown for skin and kidney and may show direct positive and negative viral interactions (60) .
In summary, HPyV NCCRs mediate key functions of polyomavirus biology, including the persistence of the episomal viral genome in the host cell nucleus as well as timing and sequential steps of the viral replication cycle. Despite some limitations, our results are informative and represent an important step toward understanding secondary HPyV cell tropism beyond HPyV surface receptors. By identifying key viral and host factors shaping the viral life cycle, models of HPyV infection, replication, and disease can be developed to identify suitable antiviral targets.
MATERIALS AND METHODS
HPyV NCCR and reporter constructs. Based on the phRG1 reporter vector (34) recapitulating the principal HPyV genome organization with respect to EVGR and LVGR ( Fig. 2A) , a smaller bidirectional reporter, pRG13D12, was constructed, in which the expression cassette for hygromycin resistance was removed, and the reporter genes were placed upstream of SV40 polyadenylation sites instead of those from beta-globin (Fig. 2B) . The HPyV NCCRs were chemically synthesized in pUC57 (Eurogentec S.A, Belgium) (Table 1) , excised using the restriction enzymes BssHII and MluI (New England BioLabs, England), and cloned into the corresponding restriction sites of pRG13D12. HPyV NCCR constructs were verified by Sanger sequencing for correct NCCR sequences and orientations using the 3130 genetic analyzer (Applied Biosystems, Switzerland). The SV40 LTag expression vector pSG-largeT was obtained from AddGene, the pRcCMV-SLT (62) was kindly provided by Ugo Moens, University of Tromso, Norway, and both were transfected using Lipofectamine 2000 as described below.
Cell lines. The cell lines, their origin and providers, and the standard culture conditions are listed in Table 2 . All cell lines were cultured in a HERA cell-150 incubator (ThermoFisher Scientific, Switzerland) at a temperature of 37°C and 5% CO 2 .
siRNA knockdown. siRNA for SV40 LTag, 5=-AAAATTGTGTACCTTTAGCTT-3= (63) , and a scramble control siRNA were synthesized (Eurogentec S.A, Belgium). To determine the effects of siRNA transfection, 1.5 ϫ 10 5 HEK293T cells were seeded in 12-well plates and transfected 24 h postseeding with 30 nM siRNAs using Lipofectamine 2000 according to the manufacturer's instructions. After 24, 48, and 72 hpt, cells were harvested for SV40 LTag and sTag immunoblotting. To analyze the effect of LTag knockdown on reporter expression, reporter plasmids were transfected at 24 h post-siRNA transfection.
Plasmid DNA transfection. Cell transfection was done in a ratio of 1:3 DNA to transfection reagent using 3 l Lipofectamine 2000 (Thermo Fisher Scientific) and 1 g plasmid construct in a 12-well plate, except for SW480 cells, which were transfected with 3 l Lipofectamine 3000 (Thermo Fisher Scientific) and 1 g plasmid constructs. For each well, 3 l of Lipofectamine 2000 (or Lipofectamine 3000) was diluted in 100 l of Opti-MEM (Thermo Fisher Scientific) medium, flicked, spun down, and incubated at room temperature (RT) for 5 min. One microgram of plasmid DNA was diluted in 100 l of Opti-MEM medium for each well. Transfection reagents and plasmid DNA were then mixed, incubated for 5 min at RT, and added to the cells with a confluence ranging between 70 and 90%. Twenty-four hours posttransfection (hpt), medium was replaced with Dulbecco's modified Eagle medium (DMEM) with 10%
